Send to a Friend Font Size: Increase Decrease

ZLAB and S1GE34 Related Headlines

Sep 1, 2025 08:00PM Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong

ZLAB and S1GE34 Related Press Releases

Sep 1, 2025 08:00PM Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong

ZLAB and S1GE34 Related SEC Filings